InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,528.93
(
-2.12%
)
US TECH 100
18,335.60
(
-0.74%
)
Dow Jones
40,936.93
(
-1.51%
)
Brent Oil
74.23
(
0.83%
)
Bitcoin
56,529.21
(
-1.57%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

retiredendof99

Send PM Follow Ignore
Followers 0
Posts 99
Boards Moderated 0
Alias Born 07/16/2006

retiredendof99

Re: mact3333 post# 3701

Friday, 05/18/2007 8:05:24 PM

Friday, May 18, 2007 8:05:24 PM

Post# of 12660
mact

OK, I might agree with you that the pps could double, but for which company? Or do you really believe both of them would double? I know that SPPI gets royalties of 10% and that GPCB would be the main beneficiary of approval (they now own the drug, although I understand it's being contested by SPPI - maybe they just want a bigger percentage in the way of royalties since they screwed up in "giving" it away) - but I'm not sure if I would think that both might double. Care to provide your rationale on the double and which company, or why both?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up